IL4 and systemic sclerosis: We hypothesize that there is a possible role of IL-4 in the pathogenesis of inflammatory arthritis in SSc patients; however, its exact role in inflammatory arthritis has yet to be established, since the accumulating evidence implies that IL-4′s anti-inflammatory properties might be beneficial in the context of inflammatory arthritis treatment [17].